Genmab A/S (GMAB) Stock Overview
Explore Genmab A/Sās financial performance, market position, analyst ratings, and future outlook.
Genmab A/S (GMAB)
Key Financials
Key Financials
Market Cap
15B
P/E Ratio
18.37
EPS (TTM)
$1.32
ROE
0.15%
GMAB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Genmab A/S (GMAB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 40.58, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $34.68.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 18.37 and a market capitalization of 15B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.